Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.

Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Abstract Text:

    muthusamy kunnimalaiyaanMuthusamy Kunnimalaiyaan,mary ndiayeMary Ndiaye,herbert chenHerbert Chen,muthusamy kunnimalaiyaanMuthusamy Kunnimalaiyaan,mary ndiayeMary Ndiaye,herbert chenHerbert Chen,muthusamy kunnimalaiyaanMuthusamy Kunnimalaiyaan,mary ndiayeMary Ndiaye,herbert chenHerbert Chen,

    BACKGROUND: We have shown previously that activation of the Raf-1/mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK)1/2 signaling pathway by ZM336372 inhibits carcinoid cells growth. In the present study, we further characterize the molecular details of the growth inhibition by the signaling-based compound ZM336372 in neuroendocrine neoplasms (NENs). METHODS: NEN cells were treated with ZM336372 (20 to 100 mumol/L) or carrier (DMSO). Western Blot was used to determine the activation of the Raf-1/MEK/ERK, other pathways activation, and cellular bioactive hormone production. RESULTS: ZM336372 in NEN cells resulted in increasing raf-1 activation and inactivation of glycogen synthase kinase-3 beta (GSK-3beta) as measured by phosphorylation of ERK1/2 and GSK-3beta, respectively. There was no alteration in the levels of phosphorylated Akt, an important mediator of the phosphatidyl inositol 3 kinase pathway. Importantly, blocking of raf-1 pathway by U0126, a potent inhibitor, in the presence of ZM336372 did not reduce the levels of p-GSK-3beta, indicating that GSK-3beta inactivation is independent of raf-1 pathway activation. Moreover, the levels of chromogranin A and achaete-scute complex like-1 reductions were persistent even after blocking the raf-1 pathway. Treatment with ZM336372 in the presence of small interfering RNA against raf-1 resulted in an increase in Raf-1 production, suggesting that ZM336372 upregulates raf-1 at the transcriptional level. CONCLUSION: This is the first description of a novel compound ZM336372 that regulates multiple pathways in NEN cells.

    Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Publishing Authors By Initials

    m kunnimalaiyaanM Kunnimalaiyaan,m ndiayeM Ndiaye,h chenH Chen,m kunnimalaiyaanM Kunnimalaiyaan,m ndiayeM Ndiaye,h chenH Chen,m kunnimalaiyaanM Kunnimalaiyaan,m ndiayeM Ndiaye,h chenH Chen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Surgery

    VOLUME: 142

    Page Numbers: 959-64; discussion 959-64

    Journal Abbreviation: Surgery

    ISSN: 1532-7361

    DAY: 7

    MONTH: Dec

    YEAR: 2007

    Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 417347

    Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.

    AFFILIATION: Endocrine Surgery Research Laboratories, Section of Endocrine Surgery, Department of Surgery, Madison, Wisconsin, USA. kunni@surgery.wisc.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: DK066169

    ACRONYM: DK

    MEDLINETA: Surgery

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News